Overview

Tech Summary

Promoter Holding

Posts

NATCOPHARM

501234567893012345678920123456789.9012345678900123456789
-2.55 (-0.48%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 535.45
1D
5D
1M
3M
1Y
5Y
Today's low
529.35
Today's high
538.6
52 week low
526.1
52 week high
1189
Volume
145400
About
Tech Summary
DMA(12)
₹672.05
DMA(50)
₹724.49
DMA(100)
₹786.93
DMA(200)
₹835.48
Fund Summary
Market Cap
₹9730.75 Cr.
Enterprise Value
₹9714.85 Cr.
No. of Shares
18.26
P/E
57.23
RoE
11.27
Debt/Equity
0.07
Valuations
PE Chart
60708090100110
PB Chart
2.53.03.5
Promoter Holdings
Public : 23.1%
FII : 11.94%
DII : 16.15%
Promoter : 48.81%
Others : 0%
Charts
Debt/Equity
0.0600.0700.0800.0900.1000.110
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
1520253035
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
0.51.01.52.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
202530354045
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Price Target Potential
Brokerage
ICICIdirect.com
Nirmal Bang
Target
955
912
Potential
9.99%
2.52%
Stock Sentiments
86% Bullish
14% Bearish
7 live trades of Rs. 85,951.85
S
shakul
 
Reputation: 0 • 
Today 3:27 PM
NATCOPHARM
50 Qty (S) Validity Over-₹32.5
E
edwinfernandes
 
Reputation: 0 • 
Jan 27 3:39 PM
NATCOPHARM
1 Qty (S) Trade entered₹3.5
Posts by FrontPage Users
NewsBot-display-image
Reputation: 29,719  •  Yesterday 9:56 PM
India’s PLI Scheme – Spell of manufacturing brilliance or a fallacy?
India’s PLI Scheme – Spell of manufacturing brilliance or a fallacy?
In 2020, the government realised the lacunas of the previous initiatives, came back to the drawing board alongside the ministries and drafted the Production
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 27, 2022 2:01 AM
These 4 pharma stocks touch their new 52-week lows
These 4 pharma stocks touch their new 52-week lows
The 52-week low is the lowest price a stock has traded during the last one year
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 22, 2022 5:16 PM
Some of the internet businesses could be dark horse of the next year: Pankaj Murarka
Some of the internet businesses could be dark horse of the next year: Pankaj Murarka
Indian companies have a very dominant market share given our low cost manufacturing base in India so I think on a broad basis most of the companies will see a very healthy profit recovery.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 5, 2022 5:51 PM
Buy Natco Pharma, target price Rs 704:  Geojit Financial Services
Buy Natco Pharma, target price Rs 704: Geojit Financial Services
Natco Pharma, incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10573.71 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Nov 21, 2022 2:01 PM
Corporate Radar: Oil India to go ex-dividend, Easy Trip Planners stock split and more
Corporate Radar: Oil India to go ex-dividend, Easy Trip Planners stock split and more
Easy Trip Planners shares will trade ex-bonus. Also, the stock will trade ex-split in the ratio of 1:2. The board of Triveni Glass will meet to consider and approve the date, time, and venue for holding the extraordinary general meeting of the company and other related matters.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Nov 18, 2022 4:21 PM
Hold Natco Pharma, target price Rs 660:  ICICI Direct
Hold Natco Pharma, target price Rs 660: ICICI Direct
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10403.02 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
RG finpati-display-image
Reputation: 3,728  •  Oct 19, 2022 6:03 AM


Natco Pharma
CMP 590,
Add more if comes near 550, SL 500, target 1050.
Timeframe 2 years.
Chartbusters - chart - 14287456
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 20, 2022 6:51 PM
Natco Pharma rises 4% on receiving court order to launch Chlorantraniliprole
Natco Pharma rises 4% on receiving court order to launch Chlorantraniliprole
Natco is the first company in India to have received its registration approval given by the Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93 per cent w/w min. under Section 9(3), said Natco Pharma in a BSE filing.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 12, 2022 4:56 PM
Stock market update: Nifty Realty index  advances  1.11% in  an upbeat  market
Stock market update: Nifty Realty index advances 1.11% in an upbeat market
The Nifty Realty index was trading 1.11 per cent up at 475.25.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 12, 2022 4:36 PM
Stock market update: Nifty Pharma index  advances  0.38% in  an upbeat  market
Stock market update: Nifty Pharma index advances 0.38% in an upbeat market
The Nifty Pharma index was trading 0.38 per cent up at 12738.15.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 8, 2022 10:51 PM
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Mahalaxmi Rub, Euro India Fresh, Arvind SmartSpaces, Sarthak Metals and Selan Expl Tech, hit their fresh 52-week highs during the day.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 8, 2022 10:36 PM
Stock market update: Nifty Bank index  advances  1.91%
Stock market update: Nifty Bank index advances 1.91%
The Nifty Bank index closed 1.91 per cent up at 40208.95.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 8, 2022 10:26 PM
Stock market update: Nifty IT index  advances  0.97%
Stock market update: Nifty IT index advances 0.97%
The Nifty IT index closed 0.97 per cent up at 28102.4.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Sep 8, 2022 9:36 PM
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
Hindalco, Tata Steel, SBI Life, Coal India Ltd and Tata Motors were among the top losers on NSE in today's trade.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Aug 12, 2022 11:26 PM
ETtech Deals Digest: UpGrad closes one of the biggest deals of the year
ETtech Deals Digest: UpGrad closes one of the biggest deals of the year
upGrad and Clevertap raised a combined $315 million this week.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Aug 8, 2022 6:46 PM
Eyestem raises Series A round from Biological E, Alkem and others
Eyestem raises Series A round from Biological E, Alkem and others
The investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Aug 8, 2022 6:11 PM
Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & Natco
Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & Natco
Existing investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Crore) post money.
The Economic Times
Like
Comment
Share
Add a comment
Revanth Nifty Radar-display-image
Reputation: 15,400  •  Jul 25, 2022 3:28 PM

#NATCOPHARM partner Breckenridge Pharma gets US FDA ANDA nod for Cabazitaxel Intravenous solution

Alert: Cabazitaxel Intravenous solution is used to treat Prostate Cancer
NATCOPHARM - 10908816
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jul 18, 2022 12:01 PM
SBI Large & mid cap mutual fund review: Can it be counted among top picks in its category?
SBI Large & mid cap mutual fund review: Can it be counted among top picks in its category?
Within the mid-cap arena, it chases absolute returns with a pure bottom-up approach. Its sizeable small-cap presence, compared to peers, is an outcome of this approach than design. After a stretch of weak performance (2018-20), the fund put in a strong show last year.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jun 29, 2022 8:06 PM
Nithya Balasubramanian on why Cipla will outperform its peers and market post FY23
Nithya Balasubramanian on why Cipla will outperform its peers and market post FY23
“In trade generics, Cipla traditionally has been a market leader and I believe that in the next three-four years, trade generics will continue to grow faster than the market and given that they are market leaders with established equity in the system and distribution muscle, I expect Cipla to grow faster.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jun 2, 2022 6:11 PM
Hold Natco Pharma, target price Rs 820:  ICICI Direct
Hold Natco Pharma, target price Rs 820: ICICI Direct
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 12776.41 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
M
Reputation: 1,160  •  Jun 2, 2022 2:42 PM

POSITIONAL LOOKS GOOD
CMP. 710
SUPPORT. 650
RESISTANCE OPEN
RSI POSITIVE DIVERSIONS ON DAILY CHARTS
Chartbusters - chart - 9627893
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  May 31, 2022 4:01 PM
Sensex  falls! These  stocks are down 5% or more on BSE
Sensex falls! These stocks are down 5% or more on BSE
In the Nifty pack, 29 stocks were trading in the green, while 21 stocks were trading in the red.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  May 31, 2022 3:56 PM
Stock market update: Stocks that hit 52-week lows on NSE
Stock market update: Stocks that hit 52-week lows on NSE
Sun Pharma, Titan Company, HDFC, HUL and Infosys were among the top losers on NSE.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  May 31, 2022 3:51 PM
Sensex  falls! But these  stocks are up over 15% on BSE
Sensex falls! But these stocks are up over 15% on BSE
In the Nifty50 index, 25 stocks were trading in the green, while 25 stocks were in the red.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  May 29, 2022 12:30 AM

#NATCOPHARM will declare results on May 30, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  May 25, 2022 7:06 PM
Patent infringement lawsuit filed against Natco by Johnson & Johnson, Momenta
Patent infringement lawsuit filed against Natco by Johnson & Johnson, Momenta
Homegrown pharma firm Natco on Wednesday said Johnson & Johnson and Momenta Pharmaceuticals have filed a patent infringement lawsuit against the company and its marketing partner Mylan Pharmaceuticals Inc, along with others, in the US. Johnson & Johnson and Momenta Pharmaceuticals lawsuit alleges infringement of two old patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate injection, Natco said in a regulatory filing.
The Economic Times
Like
Comment
Share
Add a comment
Equitymarket ಕನ್ನಡ  -display-image
Reputation: 750  •  Apr 4, 2022 2:31 PM
2 Likes
1 Comment
Share
Add a comment
EqmOptiontrading-display-image
Reputation: 828  •  Apr 4, 2022 2:29 PM
3 Likes
Comment
Share
Add a comment
Sameer -display-image
Reputation: 8,351  •  Apr 1, 2022 3:44 PM

01-04-22 Intraday BUY NATCOPHARM in cash
only Above 785
Like
2 Comments
Share
Add a comment
Traders Premier -display-image
Reputation: 2,340  •  Feb 26, 2022 2:24 AM

Natco Pharma Ltd. LTP 795.8 Yearly Low 750.45 Near to year low 6.04%
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,809  •  Feb 18, 2022 9:30 PM

ICICIdirect.com target on NATCOPHARM
Date: 18-Feb-22 Broker: ICICIdirect.com Price @ Call: 880 Target: 955 Potential: 8.52% Recommendation: HOLD
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,809  •  Feb 16, 2022 7:30 PM

Nirmal Bang target on NATCOPHARM
Date: 16-Feb-22 Broker: Nirmal Bang Price @ Call: 897 Target: 912 Potential: 1.67% Recommendation: ACCUMULATE
1 Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Feb 13, 2022 12:30 AM

#NATCOPHARM will declare results on Feb 14, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Traders Premier -display-image
Reputation: 2,340  •  Feb 9, 2022 11:39 PM

Positional Call NSE:NATCOPHARM CMP 922 buy above 944 stop loss 852.35 #turtletrade Educational purpose only
Like
Comment
Share
Add a comment
B
Reputation: 90  •  Jan 21, 2022 5:10 AM

#NATCOPHARM Natco Pharma gets non-exclusive licence to manufacture, sell anti-COVID pill Molnupiravir
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jan 20, 2022 10:21 PM
Natco Pharma signs pact with MPP to sell Molnupiravir capsules
Natco Pharma signs pact with MPP to sell Molnupiravir capsules
Natco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19. MPP had taken licence from Merck Sharp & Dohme Corp (MSD), USA for the same, the company said
The Economic Times
Like
Comment
Share
Add a comment
Daily Trade Byte-display-image
Reputation: 1,234  •  Jan 11, 2022 3:42 PM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jan 4, 2022 12:11 PM
Mankind Pharma to roll out cheapest coronavirus drug
Mankind Pharma to roll out cheapest coronavirus drug
The full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expected to hit this week in the market, he said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 30, 2021 12:26 PM
A full Molnupiravir treatment likely to cost up to Rs 3,000
A full Molnupiravir treatment likely to cost up to Rs 3,000
The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will need to swallow 40 of them during the course of the treatment.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 29, 2021 1:16 AM
Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19
Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19
Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.
The Economic Times
Like
Comment
Share
Add a comment
Clans India-display-image
Reputation: 4,139  •  Dec 28, 2021 4:42 AM
link
Open 100% Free Demat and Trading Account in just 5 Minutes – SMC Global
Open 100% Free Demat and Trading Account online in just 15 Minutes. Enjoy easy and hassle free Trading experience.
Stoxkart

Daily & Monthly Chart of #NATCOPHARM
In our view the stock has a good potential and we can see + move from here
You don't have to be expert to make money but you have to be very aware and active in the stock market
Connect with @clans team and join us for best trading experie......read more
8 Likes
Comment
Share
Add a comment
Wb Trader-display-image
Reputation: 2,761  •  Dec 27, 2021 2:39 PM

⬆️ BUY ABOVE - 857 TARGET 870,880,890 SL 850
⬇️ SELL BELOW - 850 TARGET 835,820,805 SL 857
Like
Comment
Share
Add a comment
Rupesh Singh-display-image
Reputation: 141  •  Dec 15, 2021 2:23 PM

#NATCOPHARM Today (15th Dec 2021) prediction based on past performance & technical analysis
Chartbusters - chart - 6367113
Like
Comment
Share
Add a comment
Rupesh Singh-display-image
Reputation: 141  •  Dec 15, 2021 5:12 AM
link
YouTube
Share your videos with friends, family, and the world
youtu.be
1 Like
Comment
Share
Add a comment
Beta Trader-display-image
Reputation: 2,395  •  Dec 15, 2021 2:35 AM
1 Like
Comment
Share
Add a comment
KrisDom Investor-display-image
Reputation: 29,811  •  Dec 14, 2021 11:18 PM


NATCO: CO ACQUIRED DASH PHARMACEUTICALS LLC, USA THROUGH ONE OF ITS SUBSIDIARY CO FOR CASH CONSIDERATION OF 18M USD

1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 14, 2021 9:51 PM
Natco Pharma proposes to acquire Dash Pharmaceuticals
Natco Pharma proposes to acquire Dash Pharmaceuticals
According to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA which is expected to have approximate net sales of USD 15 million for the year ending December 2021.
The Economic Times
Like
Comment
Share
Add a comment
Rupesh Singh-display-image
Reputation: 141  •  Dec 14, 2021 7:33 PM

Cheers 🥂
#NATCOPHARM 14th Dec Correct Prediction. 💥💥
Analysis on 5 Minutes Time Frame using Support & Resistance and Price Action.
Natco Pharma starts with red candle and breakdown support level and reached target level in 2nd candle.
Chartbusters - chart - 6361198
Like
Comment
Share
Add a comment
Load More Posts